Advertising policy

Surgery, Gastroenterology and Oncology does not accept any product or service marked as an advertisement on its pages. The editorial content is not influenced by financial, commercial interests or arrangements with any sponsor. Surgery, Gastroenterology and Oncology may refuse any type of advertising that is not appropriate or could be perceived as a conflict of interest with its content. Surgery, Gastroenterology and Oncology does not accept advertising for products that are harmful to health (alcohol, tobacco, etc.). Any advertisements cannot be misleading and will be verified. The product and the advertising agent must be clearly identified on the advertisement. Surgery, Gastroenterology and Oncology does not allow any advertising campaign for a drug or treatment to be targeted on an article, using its keywords. Advertisements and editorial content will be in separate sections in the journal website.

Advertising complaints policy

Any complaints regarding advertising have be sent to: editor@sgo-iasgo.com and will be handled by the Publisher and the Editorial Board.

Video Abstracts


For Authors



Journal Subscriptions

Current Issue

Jun 2022

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019
Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/